English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community

Als Association

Carol Ostrow | Nov 20, 2016

New England-based joint venture to seek ALS cure, advance treatment

Carol Ostrow | Nov 13, 2016

FDA approves unique ALS stem cell gene therapy

Amanda Rupp | Oct 30, 2016

Scientists discover new C9orf72 disease pathway

Amanda Rupp | Oct 9, 2016

Study: ALS gene creates oxidative stress in patients' DNA

Amanda Rupp | Sep 30, 2016

MT Pharma America becomes corporate sponsor for ALS

Amanda Rupp | Aug 21, 2016

Protein target found for ALS

Amanda Rupp | Aug 9, 2016

ALS, health experts broaden NeuroBANK program

Amanda Rupp | Aug 9, 2016

ALS Association, Cytokinetics renew partnership

Trending

+ Pharmaceuticals
Patient Daily | Jun 23, 2025

PhRMA says patients in the U.S. face higher prescription costs due to 340B program

+ Pharmaceuticals
Patient Daily | Jun 19, 2025

Patients Come First spokesperson on 340B reform: ‘Americans deserve a system that prioritizes patients first, not pharmacy middlemen’

+ Pharmaceuticals
Patient Daily | Jun 25, 2025

Neurosurgeon at the University of California: ‘340B is being exploited for profit, not patient care’

+ Pharmaceuticals
Patient Daily | Jun 19, 2025

FDA loophole lets low-quality drugs from China and India flood U.S. market, while American manufacturers are held to higher standards

  • « First
  • «
  • 1
  • 2
  • 3
  • 4
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2025 Patient Daily